NeuroOne Medical Technologies logo
NeuroOne Medical Technologies
NMTC | NASDAQ
Chart Builder DCF Calculator
$0.74
-$0.01 (-0.68%)
At close: Nov 16, 2026, 4:00 PM ET
$0.74
+$0.01 (+0.68%)
After-hours: Nov 16, 2026, 6:37 PM ET

NeuroOne Medical Technologies Company Profile

Company profile explained

Company Profile

NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.

Key Executives

Name Position
David A. Rosa President, Chief Executive Officer & Director
Christopher R. Volker Chief Financial Officer
Steven Mertens Chief Technology Officer
David J. Wambeke Chief Business Officer
Emily Johns Chief Administrative Officer & General Counsel
Hijaz Haris Vice President of Marketing
Mark Christianson Co-Founder, Business Development Director & Medical Sales Liaison
Parag G. Patil Chief Medical Advisor
Ronald W. McClurg Senior Advisor

Latest SEC Filings

Date Type Title
Oct 05, 2026 8-K Current Report
Sep 08, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 27, 2026 8-K Current Report
Aug 13, 2026 10-Q Quarterly Report
Aug 13, 2026 8-K Current Report
View All SEC Filings ➞
NeuroOne Medical Technologies
NeuroOne Medical Technologies logo
Country United States
IPO Date Mar 15, 2018
Industry Medical - Devices
Sector Healthcare
Employees 18
CEO David A. Rosa

Contact Details

7599 Anagram Drive Eden Prairie, Minnesota 55344 United States

Stock Details

Ticker Symbol NMTC
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001500198
CUSIP Number 64130M308
ISIN Number US64130M3088
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.